Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Income towards Parent Company (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Income towards Parent Company for 5 consecutive years, with -$4.5 million as the latest value for Q4 2020.

  • On a quarterly basis, Income towards Parent Company rose 57.55% to -$4.5 million in Q4 2020 year-over-year; TTM through Dec 2020 was -$47.0 million, a 208.96% decrease, with the full-year FY2024 number at -$36.6 million, down 12.67% from a year prior.
  • Income towards Parent Company was -$4.5 million for Q4 2020 at Forte Biosciences, up from -$5.0 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $14.8 million in Q2 2019 to a low of -$34.8 million in Q2 2020.
  • A 5-year average of -$9.3 million and a median of -$9.1 million in 2017 define the central range for Income towards Parent Company.
  • Biggest YoY gain for Income towards Parent Company was 191.71% in 2019; the steepest drop was 499.22% in 2019.
  • Forte Biosciences' Income towards Parent Company stood at -$9.0 million in 2016, then decreased by 20.89% to -$10.8 million in 2017, then plummeted by 79.15% to -$19.4 million in 2018, then skyrocketed by 45.49% to -$10.6 million in 2019, then surged by 57.55% to -$4.5 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Income towards Parent Company are -$4.5 million (Q4 2020), -$5.0 million (Q3 2020), and -$34.8 million (Q2 2020).